Elutia, Inc. (ELUT)
0.8198
-0.01
(-1.23%)
USD |
NASDAQ |
Sep 25, 16:00
0.81
-0.01
(-1.20%)
After-Hours: 19:59
Elutia Gross Profit Margin (Quarterly) : 59.62% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.62% |
| March 31, 2026 | 57.87% |
| December 31, 2025 | 58.51% |
| September 30, 2025 | 55.76% |
| June 30, 2025 | 52.89% |
| March 31, 2025 | 46.83% |
| December 31, 2024 | 46.95% |
| September 30, 2024 | 48.91% |
| June 30, 2024 | 44.49% |
| March 31, 2024 | 42.47% |
| December 31, 2023 | 36.15% |
| September 30, 2023 | 46.37% |
| June 30, 2023 | 42.73% |
| Date | Value |
|---|---|
| March 31, 2023 | 52.78% |
| December 31, 2022 | 46.51% |
| September 30, 2022 | 50.25% |
| June 30, 2022 | 38.76% |
| March 31, 2022 | 37.24% |
| December 31, 2021 | 31.21% |
| September 30, 2021 | 32.12% |
| June 30, 2021 | 46.17% |
| March 31, 2021 | 49.12% |
| December 31, 2020 | 48.30% |
| September 30, 2020 | 50.46% |
| June 30, 2020 | 44.11% |
| March 31, 2020 | 52.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
| Imunon, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -49.97% |
| Return on Invested Capital | -125.2% |
| Profit Margin (Quarterly) | -315.0% |
| Operating Margin (Quarterly) | -243.1% |
| Return on Net Operating Assets | -172.1% |